Skip to Content

G 3719 (Alprazolam 0.25 mg)

Pill imprint G 3719 has been identified as Alprazolam 0.25 mg.

Alprazolam is used in the treatment of anxiety; panic disorder; depression; tinnitus; dysautonomia and belongs to the drug class benzodiazepines. There is positive evidence of human fetal risk during pregnancy. Alprazolam 0.25 mg has a low potential for abuse relative to the drugs in schedule 3. The drug has a currently accepted medical use in treatment in the United States. Abuse of the drug may lead to limited physical dependence or psychological dependence relative to the drugs in schedule 3.

See also related documents.

Alprazolam 0.25 mg G 3719
Alprazolam 0.25 mg G 3719  Front
Alprazolam 0.25 mg G 3719  Back
Alprazolam 0.25 mg G 3719
G 3719
0.25 mg
9.00 mm
Elliptical / Oval
Prescription only
Drug Class:
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
4 - Some potential for abuse
Greenstone Limited
National Drug Code (NDC):
Inactive Ingredients:
cellulose powdered
corn starch
docusate sodium
magnesium stearate
silicon dioxide
sodium benzoate
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
54569-3755 A-S Medication Solutions, LLC (repackager)
63874-0251 Altura Pharmaceuticals Inc (repackager)
66336-0876 Dispensing Solutions Inc. (repackager)
67544-0414 Prepak Systems Inc (repackager)

Note: Inactive ingredients may vary.

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2015, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.